Things We Do For No Reason-Slides

Slides

Pdf Summary

This comprehensive document addresses two major clinical topics: restrictive red blood cell (RBC) transfusion strategies in stable hospitalized patients and the prognostic and management implications of incidental coronary artery calcification (iCAC) detected on CT scans.<br /><br />Regarding RBC transfusions, the author challenges the common practice of transfusing stable patients when hemoglobin falls below 7 g/dL, highlighting that although guidelines recommend transfusion at this threshold, there is no clear evidence that transfusion at 7 g/dL provides clinical benefit. Studies show transfusions carry risks, including transfusion-associated circulatory overload (TACO), transfusion-related acute lung injury (TRALI), antibody formation, high cost, and blood scarcity. Physiological data demonstrate that humans can tolerate significantly lower hemoglobin (as low as 5 g/dL) without tissue hypoxia due to compensatory mechanisms such as increased cardiac output and oxygen extraction. Randomized clinical trials support safety of restrictive transfusions but do not mandate immediate transfusion below 7 g/dL. The author advocates for stopping unnecessary daily phlebotomy ("bloodletting"), investigating and addressing anemia causes, and reserving transfusion for symptomatic patients, rather than relying solely on hemoglobin values.<br /><br />The second topic focuses on incidental coronary artery calcification (iCAC) detected on non-gated chest CT scans, often performed for other indications. Multiple large cohort studies (e.g., MESA, CONFIRM) and meta-analyses show that presence and severity of CAC strongly predict atherosclerotic cardiovascular disease (ASCVD) events and mortality. Visual or semi-quantitative scoring methods for iCAC correlate well with formal Agatston scoring. Studies reveal that notification of iCAC to patients and providers improves initiation and adherence to preventive therapy including statins and lifestyle changes, resulting in reduced predicted cardiovascular risk. Current guidelines from radiology and cardiology societies recommend reporting moderate or greater CAC and incorporating findings into clinical risk assessment and management. Randomized trials show that iCAC-guided therapy leads to improved risk factor control. The document encourages clinicians not to ignore iCAC findings, use them to guide preventive care, and integrate reporting into routine practice.<br /><br />In summary, the document calls for critical re-evaluation of routine transfusions at arbitrary hemoglobin thresholds in stable patients, favoring symptom-based management and anemia cause investigation. It also emphasizes leveraging incidental coronary calcium imaging to enhance cardiovascular risk stratification and treatment optimization. Both themes challenge entrenched practices and aim to improve patient outcomes through evidence-based, physiologically rational, and cost-conscious care.

Keywords

restrictive red blood cell transfusion

hemoglobin threshold

transfusion risks

transfusion-associated circulatory overload

incidental coronary artery calcification

non-gated chest CT

atherosclerotic cardiovascular disease prediction

Agatston scoring

preventive cardiovascular therapy

evidence-based transfusion management